The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prussin, C.
Right arrow Articles by Foster, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prussin, C.
Right arrow Articles by Foster, B.

The Journal of Immunology, Vol 159, Issue 12 5862-5870, Copyright © 1997 by American Association of Immunologists

ARTICLES

TCR V alpha 24 and V beta 11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation

C Prussin and B Foster
Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892-1881, USA. calman@nih.gov

Murine NK1 natural T (NT) cells are a population of alphabeta T cells that express NK cell receptors and an invariant TCR rearrangement. These cells rapidly produce large amounts of IL-4 upon activation and have been suggested to promote Th2 differentiation. We sought to determine whether a human NK1 T cell analogue could be detected in PBMC, and if so, characterize the TCR usage, cytokine expression, and surface phenotype of this subset. Using flow cytometry, we have demonstrated a distinct population of V alpha24+, V beta11+, CD56+ T cells consistent with NT cells. Upon sequencing, these cells expressed an invariant V alpha24-J alphaQ TCR rearrangement, verifying their identity as a human NK1 T cell analogue. NT cells demonstrated increased frequencies of both IFN-gamma and IL-4 production. Strikingly, 30 to 45% of CD4+ NT cells expressed IL-4, a sixfold greater frequency than that seen in mainstream CD4+ alphabeta T cells. Contrary to the pattern seen with mainstream T cells, virtually all IL- 4-producing NT cells coexpressed IFN-gamma, indicating that this subset of NT cells has a unique Th0 phenotype. These data establish that V alpha24+ NT cells are a potent source of IL-4 and as such, may play a role in Th2 priming in human immune responses. This work demonstrates that human NT cells can be phenotypically identified and functionally studied in the blood of healthy or diseased subjects.


This article has been cited by other articles:


Home page
 GutHome page
E Zigmond, S Preston, O Pappo, G Lalazar, M Margalit, Z Shalev, L Zolotarov, D Friedman, R Alper, and Y Ilan
{beta}-Glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders
Gut, January 1, 2007; 56(1): 82 - 89.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Sen, B. Yongyi, H. Yuling, X. Luokun, H. Li, X. Jie, D. Tao, Z. Gang, L. Junyan, H. Chunsong, et al.
V{alpha}24-Invariant NKT Cells from Patients with Allergic Asthma Express CCR9 at High Frequency and Induce Th2 Bias of CD3+ T Cells upon CD226 Engagement
J. Immunol., October 15, 2005; 175(8): 4914 - 4926.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. V. Baev, X.-h. Peng, L. Song, J. R. Barnhart, G. M. Crooks, K. I. Weinberg, and L. S. Metelitsa
Distinct homeostatic requirements of CD4+ and CD4- subsets of V{alpha}24-invariant natural killer T cells in humans
Blood, December 15, 2004; 104(13): 4150 - 4156.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. J. Wajchman, C. W. Pierce, V. A. Varma, M. M. Issa, J. Petros, and K. E. Dombrowski
Ex Vivo Expansion of CD8+CD56+ and CD8+CD56- Natural Killer T Cells Specific for MUC1 Mucin
Cancer Res., February 1, 2004; 64(3): 1171 - 1180.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Cookson and D. Reen
IL-15 drives neonatal T cells to acquire CD56 and become activated effector cells
Blood, September 15, 2003; 102(6): 2195 - 2197.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. Motsinger, A. Azimzadeh, A. K. Stanic, R. P. Johnson, L. Van Kaer, S. Joyce, and D. Unutmaz
Identification and Simian Immunodeficiency Virus Infection of CD1d-Restricted Macaque Natural Killer T Cells
J. Virol., July 15, 2003; 77(14): 8153 - 8158.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. L. Gansert, V. Kiebler, M. Engele, F. Wittke, M. Rollinghoff, A. M. Krensky, S. A. Porcelli, R. L. Modlin, and S. Stenger
Human NKT Cells Express Granulysin and Exhibit Antimycobacterial Activity
J. Immunol., March 15, 2003; 170(6): 3154 - 3161.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
M. Araki, T. Kondo, J. E. Gumperz, M. B. Brenner, S. Miyake, and T. Yamamura
Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission
Int. Immunol., February 1, 2003; 15(2): 279 - 288.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. H. Kim, B. Johnston, and E. C. Butcher
Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among Valpha 24+Vbeta 11+ NKT cell subsets with distinct cytokine-producing capacity
Blood, June 17, 2002; 100(1): 11 - 16.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. J. J. van der Vliet, B. M. E. von Blomberg, M. D. Hazenberg, N. Nishi, S. A. Otto, B. H. van Benthem, M. Prins, F. A. Claessen, A. J. M. van den Eertwegh, G. Giaccone, et al.
Selective Decrease in Circulating V{alpha}24+V{beta}11+ NKT Cells During HIV Type 1 Infection
J. Immunol., February 1, 2002; 168(3): 1490 - 1495.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Muhammad Ali Tahir, O. Cheng, A. Shaulov, Y. Koezuka, G. J. Bubley, S. B. Wilson, S. P. Balk, and M. A. Exley
Loss of IFN-{gamma} Production by Invariant NK T Cells in Advanced Cancer
J. Immunol., October 1, 2001; 167(7): 4046 - 4050.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Dunne, S. Lynch, C. O'Farrelly, S. Todryk, J. E. Hegarty, C. Feighery, and D. G. Doherty
Selective Expansion and Partial Activation of Human NK Cells and NK Receptor-Positive T Cells by IL-2 and IL-15
J. Immunol., September 15, 2001; 167(6): 3129 - 3138.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. L. Chan, N. Pejnovic, C. A. Lee, and N. A. Al-Ali
Human IL-18 Receptor and ST2L Are Stable and Selective Markers for the Respective Type 1 and Type 2 Circulating Lymphocytes
J. Immunol., August 1, 2001; 167(3): 1238 - 1244.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
N. Kadowaki, S. Antonenko, S. Ho, M.-C. Rissoan, V. Soumelis, S. A. Porcelli, L. L. Lanier, and Y.-J. Liu
Distinct Cytokine Profiles of Neonatal Natural Killer T Cells after Expansion with Subsets of Dendritic Cells
J. Exp. Med., May 21, 2001; 193(10): 1221 - 1226.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. J. Sayers, A. D. Brooks, J. M. Ward, T. Hoshino, W. E. Bere, G. W. Wiegand, J. M. Kelley, and M. J. Smyth
The Restricted Expression of Granzyme M in Human Lymphocytes
J. Immunol., January 15, 2001; 166(2): 765 - 771.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z. Illes, T. Kondo, J. Newcombe, N. Oka, T. Tabira, and T. Yamamura
Differential Expression of NK T Cell V{alpha}24J{alpha}Q Invariant TCR Chain in the Lesions of Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy
J. Immunol., April 15, 2000; 164(8): 4375 - 4381.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H. J. J. van der Vliet, N. Nishi, T. D. de Gruijl, B. M. E. von Blomberg, A. J. M. van den Eertwegh, H. M. Pinedo, G. Giaccone, and R. J. Scheper
Human natural killer T cells acquire a memory-activated phenotype before birth
Blood, April 1, 2000; 95(7): 2440 - 2442.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. J. Pittet, D. E. Speiser, D. Valmori, J.-C. Cerottini, and P. Romero
Cutting Edge: Cytolytic Effector Function in Human Circulating CD8+ T Cells Closely Correlates with CD56 Surface Expression
J. Immunol., February 1, 2000; 164(3): 1148 - 1152.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Zeng, G. Gazit, S. Dejbakhsh-Jones, S. P. Balk, S. Snapper, M. Taniguchi, and S. Strober
Heterogeneity of NK1.1+ T Cells in the Bone Marrow: Divergence from the Thymus
J. Immunol., November 15, 1999; 163(10): 5338 - 5345.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
D. E. Speiser, M. J. Pittet, D. Valmori, R. Dunbar, D. Rimoldi, D. Lienard, H. R. MacDonald, J.-C. Cerottini, V. Cerundolo, and P. Romero
In Vivo Expression of Natural Killer Cell Inhibitory Receptors by Human Melanoma–specific Cytolytic T Lymphocytes
J. Exp. Med., September 20, 1999; 190(6): 775 - 782.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. G. Doherty, S. Norris, L. Madrigal-Estebas, G. McEntee, O. Traynor, J. E. Hegarty, and C. O'Farrelly
The Human Liver Contains Multiple Populations of NK Cells, T Cells, and CD3+CD56+ Natural T Cells with Distinct Cytotoxic Activities and Th1, Th2, and Th0 Cytokine Secretion Patterns
J. Immunol., August 15, 1999; 163(4): 2314 - 2321.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Han, L. Harrison, P. Kehn, K. Stevenson, J. Currier, and M. A. Robinson
Invariant or Highly Conserved TCR {alpha} Are Expressed on Double-Negative (CD3+CD4-CD8-) and CD8+ T Cells
J. Immunol., July 1, 1999; 163(1): 301 - 311.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
F. Tilloy, E. Treiner, S.-H. Park, C. Garcia, F. Lemonnier, H. de la Salle, A. Bendelac, M. Bonneville, and O. Lantz
An Invariant T Cell Receptor alpha  Chain Defines a Novel TAP-independent Major Histocompatibility Complex Class Ib-restricted alpha /beta T Cell Subpopulation in Mammals
J. Exp. Med., June 21, 1999; 189(12): 1907 - 1921.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
K. Benlagha, A. Weiss, A. Beavis, L. Teyton, and A. Bendelac
In Vivo Identification of Glycolipid Antigen-specific T Cells Using Fluorescent CD1d Tetramers
J. Exp. Med., June 6, 1999; 191(11): 1895 - 1904.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
T. Kawano, Y. Tanaka, E. Shimizu, Y. Kaneko, N. Kamata, H. Sato, H. Osada, S. Sekiya, T. Nakayama, and M. Taniguchi
A novel recognition motif of human NKT antigen receptor for a glycolipid ligand
Int. Immunol., June 1, 1999; 11(6): 881 - 887.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. Reinhardt and A. Melms
Elevated frequencies of natural killer T lymphocytes in myasthenia gravis
Neurology, April 1, 1999; 52(7): 1485 - 1485.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
M. Korsgren, C. G.A. Persson, F. Sundler, T. Bjerke, T. Hansson, B. J. Chambers, S. Hong, L. Van Kaer, H.-G. Ljunggren, and O. Korsgren
Natural Killer Cells Determine Development of Allergen-induced Eosinophilic Airway Inflammation in Mice
J. Exp. Med., February 1, 1999; 189(3): 553 - 562.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
F. M. Spada, Y. Koezuka, and S. A. Porcelli
CD1d-restricted Recognition of Synthetic Glycolipid Antigens by Human Natural Killer T Cells
J. Exp. Med., October 19, 1998; 188(8): 1529 - 1534.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
M. Exley, S. Porcelli, M. Furman, J. Garcia, and S. Balk
CD161 (NKR-P1A) Costimulation of CD1d-dependent Activation of Human T Cells Expressing Invariant Valpha 24Jalpha Q T Cell Receptor alpha  Chains
J. Exp. Med., September 7, 1998; 188(5): 867 - 876.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
A. Motsinger, D. W. Haas, A. K. Stanic, L. Van Kaer, S. Joyce, and D. Unutmaz
CD1d-restricted Human Natural Killer T Cells Are Highly Susceptible to Human Immunodeficiency Virus 1 Infection
J. Exp. Med., April 1, 2002; 195(7): 869 - 879.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.